Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.14 (-8.64%)
Close on Nov 16, 2026Market cap $55.39MP/E –Yield –
Tenax Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Tenax Therapeutics's total debt was $31.08K at Mar 31, 2021. For fiscal 2020 it was $124.17K. The highest annual figure on record is $4.46M in fiscal 2011.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $124.17K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2014 | Apr 30, 2014 | $0 | -100.0% |
| FY2013 | Apr 30, 2013 | $2.99M | +120.0% |
| FY2012 | Apr 30, 2012 | $1.36M | -69.5% |
| FY2011 | Apr 30, 2011 | $4.46M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $31.08K | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $124.17K | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $213.76K | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $137.05K | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $0 | – |
See a number that looks wrong?